Ben Tseng - Concepedia

Author

Ben Tseng

University of California San Diego

Also Known As

B Tseng, B Y Tseng, B Y. Tseng, B. Tseng, B. Y. Tseng, B.Y. Tseng, BEN Y. TSENG, Ben Tseng, Ben Y. TSENG, Ben Y. Tseng

104

Publications

6.7K

Citations

H-Index

134

Concepts

All Affiliations

University of California San Diego Maxim Integrated (United States)Epic Sciences (United States)Myriad Genetics

About

Ben Tseng is an author at University of California San Diego specializing in medicine, natural sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	60	4.8K
2	Arts	1	1	13
3	Engineering	1	1	70
4	Health Sciences	1	1	27
5	Language Studies	1	1	13

Ben Tseng

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
Why target apoptosis in cancer treatment? Shailaja Kasibhatla, Ben Tseng PubMed Tumor BiologyChemoprevention StrategyMedicineApoptosisImmunology	2003	354
Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4<i>H</i>-chromenes, a novel series of anticancer agents Henriette Gourdeau, Lorraine Leblond, Bettina A. Hamelin, Molecular Cancer Therapeutics	2004	285
Methotrexate-induced misincorporation of uracil into DNA Mehran Goulian, B. Bleile, Ben Tseng Proceedings of the National Academy of Sciences	1980	281
Discovery of 4-Aryl-4<i>H</i>-chromenes as a New Series of Apoptosis Inducers Using a Cell- and Caspase-based High-Throughput Screening Assay. 1. Structure−Activity Relationships of the 4-Aryl Group William Kemnitzer, John Drewe, Songchun Jiang, Journal of Medicinal Chemistry	2004	278
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure–activity relationships of the 7- and 5-, 6-, 8-positions William Kemnitzer, Shailaja Kasibhatla, Songchun Jiang, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryOxysterolBiochemistryMedicineNatural Sciences	2005	269
Discovery and Structure−Activity Relationship of 3-Aryl-5-aryl-1,2,4-oxadiazoles as a New Series of Apoptosis Inducers and Potential Anticancer Agents Han‐Zhong Zhang, Shailaja Kasibhatla, Jared Kuemmerle, Journal of Medicinal Chemistry ApoptosisCell DeathNew SeriesT47d CellsPharmaceutical Chemistry	2005	234
Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay Han‐Zhong Zhang, Shailaja Kasibhatla, Yan Wang, Bioorganic & Medicinal Chemistry Medicinal ChemistryChemoprevention StrategyMedicineApoptosisImmunology	2003	234
A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid Shailaja Kasibhatla, Katayoun A. Jessen, Sergei Maliartchouk, Proceedings of the National Academy of Sciences Chemoprevention StrategyApoptosisImmunologyCell DeathPharmacotherapy	2005	211
Discovery of 4-Aryl-4<i>H</i>-chromenes as a New Series of Apoptosis Inducers Using a Cell- and Caspase-Based High Throughput Screening Assay. 4. Structure–Activity Relationships of <i>N</i>-Alkyl Substituted Pyrrole Fused at the 7,8-Positions William Kemnitzer, John Drewe, Songchun Jiang, Journal of Medicinal Chemistry Chemoprevention StrategyApoptosisCell DeathNew SeriesHeterocycle Chemistry	2008	205
Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. S. Huang, Nanping Wang, Ben Tseng, The EMBO Journal Sv40 T AntigenImmunologyRetinoblastoma ProteinPathologyAntigen Processing	1990	202

Page 1